TY  - GEN
AU  - Stynes,Gillian
AU  - Svedsater,Henrik
AU  - Wex,Jaro
AU  - Lettis,Sally
AU  - Leather,David
AU  - Castelnuovo,Emanuela
AU  - Detry,Michelle
AU  - Berry,Scott
TI  - Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy
SN  - 1465-993X
PY  - 2016///0407
KW  - Administration, Inhalation
KW  - Adrenal Cortex Hormones
KW  - administration & dosage
KW  - Adrenergic beta-2 Receptor Agonists
KW  - Aged
KW  - Androstadienes
KW  - Bayes Theorem
KW  - Benzyl Alcohols
KW  - Bronchodilator Agents
KW  - Budesonide, Formoterol Fumarate Drug Combination
KW  - Chlorobenzenes
KW  - Disease Progression
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluticasone-Salmeterol Drug Combination
KW  - Forced Expiratory Volume
KW  - Humans
KW  - Lung
KW  - drug effects
KW  - Male
KW  - Middle Aged
KW  - Pulmonary Disease, Chronic Obstructive
KW  - diagnosis
KW  - Randomized Controlled Trials as Topic
KW  - Recovery of Function
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
UR  - https://doi.org/10.1186/s12931-015-0184-8
ER  -